120 related articles for article (PubMed ID: 10560618)
1. Effects of ulcerative colitis activity on plasma and mucosal prostaglandin E2 concentration.
Wiercińska-Drapało A; Flisiak R; Prokopowicz D
Prostaglandins Other Lipid Mediat; 1999 Oct; 58(2-4):159-65. PubMed ID: 10560618
[TBL] [Abstract][Full Text] [Related]
2. Plasma and mucosal prostaglandin E2 as a surrogate marker of ulcerative colitis activity.
Wiercińska-Drapało A; Flisiak R; Prokopowicz D
Rocz Akad Med Bialymst; 2001; 46():60-8. PubMed ID: 11780581
[TBL] [Abstract][Full Text] [Related]
3. Mucosal and plasma prostaglandin E2 in ulcerative colitis.
Wiercinska-Drapalo A; Flisiak R; Prokopowicz D
Hepatogastroenterology; 1999; 46(28):2338-42. PubMed ID: 10521993
[TBL] [Abstract][Full Text] [Related]
4. Studies on changes of colonic mucosal PGE2 levels and tissue localization in experimental colitis.
Yamashita S
Gastroenterol Jpn; 1993 Apr; 28(2):224-35. PubMed ID: 8486212
[TBL] [Abstract][Full Text] [Related]
5. Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis.
Raab Y; Sundberg C; Hällgren R; Knutson L; Gerdin B
Am J Gastroenterol; 1995 Apr; 90(4):614-20. PubMed ID: 7717321
[TBL] [Abstract][Full Text] [Related]
6. Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis.
Rampton DS; Sladen GE; Youlten LJ
Gut; 1980 Jul; 21(7):591-6. PubMed ID: 7429322
[TBL] [Abstract][Full Text] [Related]
7. Inter-relationships between inflammatory mediators released from colonic mucosa in ulcerative colitis and their effects on colonic secretion.
Wardle TD; Hall L; Turnberg LA
Gut; 1993 Apr; 34(4):503-8. PubMed ID: 8491398
[TBL] [Abstract][Full Text] [Related]
8. Colonic mucosal hemodynamics and tissue oxygenation in patients with ulcerative colitis: investigation by organ reflectance spectrophotometry.
Tsujii M; Kawano S; Tsuji S; Kobayashi I; Takei Y; Nagano K; Fusamoto H; Kamada T; Ogihara T; Sato N
J Gastroenterol; 1995 Apr; 30(2):183-8. PubMed ID: 7773348
[TBL] [Abstract][Full Text] [Related]
9. Glutathione content of colonic mucosa: evidence for oxidative damage in active ulcerative colitis.
Holmes EW; Yong SL; Eiznhamer D; Keshavarzian A
Dig Dis Sci; 1998 May; 43(5):1088-95. PubMed ID: 9590426
[TBL] [Abstract][Full Text] [Related]
10. Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial.
Langhorst J; Boone J; Lauche R; Rueffer A; Dobos G
J Crohns Colitis; 2016 Jul; 10(7):786-94. PubMed ID: 26874351
[TBL] [Abstract][Full Text] [Related]
11. Plasma interleukin-18 reflects severity of ulcerative colitis.
Wiercinska-Drapalo A; Flisiak R; Jaroszewicz J; Prokopowicz D
World J Gastroenterol; 2005 Jan; 11(4):605-8. PubMed ID: 15641156
[TBL] [Abstract][Full Text] [Related]
12. Application of clinical indexes in ulcerative colitis patients in regular follow-up visit: correlation with endoscopic 'mucosal healing' and implication for management. Preliminary results.
Pagnini C; Menasci F; Festa S; Rizzatti G; Corleto VD; Delle Fave MM; D'Ambra G; Di Giulio E; Delle Fave G
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3674-81. PubMed ID: 26502857
[TBL] [Abstract][Full Text] [Related]
13. Greatly increased mucosal nitric oxide in ulcerative colitis determined in situ by a novel nitric oxide-selective microelectrode.
Iwashita E
J Gastroenterol Hepatol; 1998 Apr; 13(4):391-5. PubMed ID: 9641303
[TBL] [Abstract][Full Text] [Related]
14. Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.
Lauritsen K; Hansen J; Bytzer P; Bukhave K; Rask-Madsen J
Gut; 1984 Nov; 25(11):1271-8. PubMed ID: 6149981
[TBL] [Abstract][Full Text] [Related]
15. Mucosal metabolism in ulcerative colitis and Crohn's disease.
Duffy MM; Regan MC; Ravichandran P; O'Keane C; Harrington MG; Fitzpatrick JM; O'Connell PR
Dis Colon Rectum; 1998 Nov; 41(11):1399-405. PubMed ID: 9823806
[TBL] [Abstract][Full Text] [Related]
16. Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients.
Frommel TO; Dyavanapalli M; Oldham T; Kazi N; Lietz H; Liao Y; Mobarhan S
Clin Cancer Res; 1997 Feb; 3(2):209-13. PubMed ID: 9815674
[TBL] [Abstract][Full Text] [Related]
17. Dietary monounsaturated n-3 and n-6 long-chain polyunsaturated fatty acids affect cellular antioxidant defense system in rats with experimental ulcerative colitis induced by trinitrobenzene sulfonic acid.
Nieto N; Fernandez MI; Torres MI; Ríos A; Suarez MD; Gil A
Dig Dis Sci; 1998 Dec; 43(12):2676-87. PubMed ID: 9881500
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal/permeability-increasing protein in colonic mucosa in ulcerative colitis.
Haapamäki MM; Häggblom JO; Grönroos JM; Pekkala E; Alanen K; Nevalainen TJ
Hepatogastroenterology; 1999; 46(28):2273-7. PubMed ID: 10521980
[TBL] [Abstract][Full Text] [Related]
19. Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis.
Casellas F; Papo M; Guarner F; Antolín M; Segura RM; Armengol JR; Malagelada JR
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):221-6. PubMed ID: 7743303
[TBL] [Abstract][Full Text] [Related]
20. Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease.
Dai L; King DW; Perera DS; Lubowski DZ; Burcher E; Liu L
Dig Dis Sci; 2015 May; 60(5):1236-46. PubMed ID: 25666316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
